黄俊廷

　　2014年获中山大学肿瘤防治中心肿瘤学博士学位。擅长18岁以下的儿童、青少年恶性肿瘤的化疗，尤其对儿童、青少年淋巴瘤、白血病和常见实体瘤（神经母细胞瘤、横纹肌肉瘤、肾母细胞瘤、尤文氏肉瘤、髓母细胞瘤、肝母细胞瘤、生殖细胞瘤、骨肉瘤、朗格罕氏组织细胞增生症、横纹肌样瘤、胰母细胞瘤、滑膜肉瘤、纤维肉瘤和肺母细胞瘤等）的基础和临床有深入研究。在国内外核心专业期刊发表文章多篇，多次在学术会议上发言。参与《儿童淋巴瘤诊断与治疗》、《临床药物治疗学肿瘤分册》、《软组织肉瘤治疗》等多本专著的编写。

发表文章：
1.Zhang, Y.; Huang, J.; Chen, J.; Yang, K.; Chen, J.; Xu, L.; Zhou, Z.; Chen, M., The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study. Cancer Manag Res 2018, 10, 599-611.
2.Yang, K. B.; Sun, X. F.; Zhen, Z. Z.; Lu, S. Y.; Zhu, J.; Sun, F. F.; Wang, J.; Huang, J. T.; Chen, R. R.; Ye, L. T., Impact of intensified maintenance therapy on the prognosis of children and adolescents with advanced lymphoblastic lymphoma. Zhonghua xue ye xue za zhi= Zhonghua xueyexue zazhi 2017, 38, (9), 778-783.
3.Huang, J.; Tan, Y.; Zhen, Z.; Lu, S.; Sun, F.; Zhu, J.; Wang, J.; Liao, R.; Sun, X., Role of post-chemotherapy radiation in the management of children and adolescents with primary advanced malignant mediastinal germ cell tumors. PloS one 2017, 12, (8), e183219.
4.廖茹; 甄子俊; 朱佳; 王娟; 路素英; 孙斐斐; 黄俊廷; 郭晓芳; 孙晓非, 骨髓转移的高危神经母细胞瘤治疗后骨髓缓解速度与预后关系. 中国小儿血液与肿瘤杂志 2017, (1), 7-13.
5.杨凯彬; 孙晓非; 甄子俊; 路素英; 朱佳; 孙斐斐; 王娟; 黄俊廷; 陈日荣; 叶莉彤; 刘颖; 游志瑶, 提高维持治疗强度对Ⅲ期和Ⅳ期儿童青少年淋巴母细胞淋巴瘤患者预后的影响. 中华血液学杂志 2017, (9), 778-783.
6.黄俊廷; 谭玉婷; 甄子俊; 路素英; 孙斐斐; 朱佳; 王娟; 孙晓非, 87例儿童青少年Ⅲ～Ⅳ期预后良好型肾母细胞瘤综合治疗结果分析. 广东医学 2017, (20), 3116-3119.
7.Zhen, Z.; Guo, X.; Zhu, J.; Lu, S.; Sun, F.; Wang, J.; Huang, J.; Liao, R.; Sun, X., Effect of chemotherapy alone with adult chemotherapy regimens on prognosis of children and adolescents with Hodgkin's disease. Japanese journal of clinical oncology 2016, 46, (7), 667-673.
8.Lu, S.; Chang, H.; Sun, X.; Zhen, Z.; Sun, F.; Zhu, J.; Wang, J.; Huang, J.; Liao, R.; Guo, X., Long-term outcomes of nasopharyngeal carcinoma in 148 children and adolescents. Medicine 2016, 95, (17). 
9.朱佳; 甄子俊; 王娟; 李鹏飞; 路素英; 孙斐斐; 黄俊廷; 郭晓芳; 廖茹, 中危神经母细胞瘤患者临床和生存分析. 中国小儿血液与肿瘤杂志 2016, (3), 117-121.
10.郭晓芳; 王娟; 孙斐斐; 甄子俊; 朱佳; 路素英; 黄俊廷; 李鹏飞; 廖茹, 外周血淋巴细胞和单核细胞比值对儿童霍奇金淋巴瘤预后的意义. 中国小儿血液与肿瘤杂志 2016, (4), 178-184. 
11.Zhou, D.; Zhang, Y.; Xu, L.; Zhou, Z.; Huang, J.; Chen, M., A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma. Scientific reports 2015, 5. 
12.Xu, L.; Gao, H.; Huang, J.; Wang, H.; Zhou, Z.; Zhang, Y.; Li, S.; Chen, M., Antiviral therapy in the improvement of survival of patients with hepatitis B virus‐related hepatocellular carcinoma treated with sorafenib. Journal of gastroenterology and hepatology 2015, 30, (6), 1032-1039.
13.Zhou, D.; Xu, L.; Luo, Y.; He, F.; Huang, J.; Zhang, Y.; Chen, M., Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization. World Journal of Gastroenterology: WJG 2015, 21, (18), 5582.
14.Wu, Q.; Zhang, H.; Chen, M.; Zhang, Y.; Huang, J.; Xu, Z.; Wang, W., Preparation of carbon‐coated iron nanofluid and its application in radiofrequency ablation. Journal of Biomedical Materials Research Part B: Applied Biomaterials 2015, 103, (4), 908-914. 
15.孙斐斐; 甄子俊; 朱佳; 王娟; 路素英; 黄俊廷; 李鹏飞; 郭晓芳; 廖如, 儿童低危神经母细胞瘤临床分析. 广东医学 2015, (17), 2635-2638.
16.Huang, J.; Xu, L.; Luo, Y.; He, F.; Zhang, Y.; Chen, M., The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy. Medical Oncology 2014, 31, (4), 883.
17.Heng Jun, G.; Yao Jun, Z.; Min Shan, C.; Mei Xian, C.; Jun Ting, H.; Li, X.; Lau, W. Y., Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV‐related hepatocellular carcinoma. Liver International 2014, 34, (4), 612-620.
18.刘芙蓉; 但家强; 张耀军; 陈敏山; 黄俊廷; 谢汝石, HBV相关性肝癌射频消融和手术切除术后HBV激活率的比较. 中华肝脏病杂志 2014, (1), 38-42.
19.Huang, J.; Zhang, Y.; Peng, Z.; Gao, H.; Xu, L.; Jiao, L. R.; Chen, M., A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy. Journal of cancer research and clinical oncology 2013, 139, (10), 1709-1719. 
20.Huang, J.; Huang, J.; Xu, L.; Chen, M.; Chen, M.; Zhang, Y., Family history of hepatocellulcar carcinoma is not associated with its patients’ prognosis after hepatectomy. World journal of surgical oncology 2013, 11, (1), 280.
21.Dan, J.; Zhang, Y.; Peng, Z.; Huang, J.; Gao, H.; Xu, L.; Chen, M., Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PloS one 2013, 8, (3), e58184.
22.Dan, J.; Zhang, Y.; Huang, J.; Chen, M.; Gao, H.; Peng, Z.; Xu, L.; Lau, W. Y., Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study. European Journal of Surgical Oncology (EJSO) 2013, 39, (8), 865-872.
23.Zhang, Y.; Peng, Z.; Chen, M.; Liu, F.; Huang, J.; Xu, L.; Zhang, Y.; Chen, M., Elevated neutrophil to lymphocyte ratio might predict poor prognosis for colorectal liver metastasis after percutaneous radiofrequency ablation. International Journal of Hyperthermia 2012, 28, (2), 132-140.
24.劳向明; 张海燕; 李锦清; 陈易明; 黄俊廷; 张亚奇; 郑云, 碳包铁纳米晶对表阿霉素的吸附与缓释作用. 南方医科大学学报 2008, (8), 1331-1334, 1338.